5-aza-2′-deoxycytidine

We are 5-aza-2′-deoxycytidine CAS:2353-33-5 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:5-aza-2'-deoxycytidine
CAS.NO:2353-33-5
Synonyms:DECITABINE
4-Amino-1-(2-deoxy-β-D-ribofuranosyl)-1,3,5-triazin-2(1H)-one
5-AZA-2'-DEOXYCYTIDINE
5-AZA-CDR
2'-Deoxy-5-azacytidine
Molecular Formula:C8H12N4O4
Molecular Weight:228.20500
 
Physical and Chemical Properties:
Density:1.9
Melting point:200ºC
Boiling point:485.8ºC
Flash point:247.6ºC
Index of Refraction:1.779
 
Specification:
Appearance:White to off-white powder
Assay(HPLC):≥99.0%
Loss on drying:≤0.5%
Residue on ignition:≤0.5%
Heavy metal:≤10ppm
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:5-Aza-2’-deoxy Cytidine is used as cancer treatment, in particular to inhibit the growth of pancreatic endocrine tumor cell lines.

5-aza-2'-deoxycytidine


Related News: Onconova Therapeutics, Inc. and Inceptua Medicines Access (a business unit of the Inceptua Group) recently announced they have entered into a collaboration to make available intravenous rigosertib via a Pre-approval Access Program in selected countries around the world.863991-04-2 Fate Therapeutics, Inc. recently announced new in vivo preclinical data for FT819, its first off-the-shelf, iPSC-derived chimeric antigen receptor (CAR) T-cell product candidate, at the 61st American Society of Hematology (ASH) Meeting and Exposition in Orlando, FL.2-Bromophenol Catalent, a global leader in clinical supply services, recently announced the launch of its new CTSuccessTM clinical trial planning service, designed to support trial sponsors with earlier, more proactive and robust clinical supply chain planning, and reduce the risk of delays and budget overspend common to clinical trials as they progress.4-Isopropylbenzeneboronic Acid Catalent, a global leader in clinical supply services, recently announced the launch of its new CTSuccessTM clinical trial planning service, designed to support trial sponsors with earlier, more proactive and robust clinical supply chain planning, and reduce the risk of delays and budget overspend common to clinical trials as they progress.The company’s pharmaceutical intermediate business is expected to maintain a growth rate of more than 30%.

Related Products
Product Name
3-Fluoro-5-methylbenzoic acid View Details
Isobutylboronic Acid View Details
Acetyl bromide View Details
Methyl 6-bromopicolinate manufacturer 2-Propoxyethyl Chloride manufacturer 2,2,2-Trifluoroethanol manufacturer Octyl gallate manufacturer Pixantrone manufacturer